FDA approves naloxone injection to counteract opioid overdoses

FDA approves ZIMHI (naloxone hydrochloride) injection as an additional option to treat opioid overdose.

Source: FDA Center for Drug Evaluation and Research - What's New - October 18, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news